Covered recipient · General Payments record
BRUCE K HIRA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$7,087.09
- Reported across 420 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $527.52 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $161.29 | 7 |
| Novo Nordisk AS | $144.30 | 10 |
| Bayer HealthCare Pharmaceuticals Inc. | $54.40 | 2 |
| PFIZER INC. | $52.65 | 2 |
| GlaxoSmithKline, LLC. | $28.51 | 1 |
| Acerta Pharma LLC | $27.81 | 1 |
| Amgen Inc. | $20.82 | 1 |
| Exact Sciences Corporation | $19.39 | 1 |
| Lilly USA, LLC | $18.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.45 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921831 | CMS |
| ABBVIE INC. | $27.19 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921833 | CMS |
| ABBVIE INC. | $23.07 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921835 | CMS |
| ABBVIE INC. | $28.13 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921837 | CMS |
| ABBVIE INC. | $23.86 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921839 | CMS |
| ABBVIE INC. | $28.11 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921841 | CMS |
| ABBVIE INC. | $5.48 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921843 | CMS |
| Amgen Inc. | $20.82 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117278150 | CMS |
| AstraZeneca Pharmaceuticals LP | $27.81 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104277263 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $28.34 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086262364 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $26.06 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086222158 | CMS |
| Exact Sciences Corporation | $19.39 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114703533 | CMS |
| GlaxoSmithKline, LLC. | $28.51 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116450445 | CMS |
| Lilly USA, LLC | $18.35 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136080858 | CMS |
| Novo Nordisk Inc | $6.71 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096871716 | CMS |
| Novo Nordisk Inc | $12.27 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097184923 | CMS |
| Novo Nordisk Inc | $7.19 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096861720 | CMS |
| Novo Nordisk Inc | $15.51 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097029780 | CMS |
| Novo Nordisk Inc | $22.27 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096623228 | CMS |
| Novo Nordisk Inc | $7.86 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096595270 | CMS |
| Novo Nordisk Inc | $16.89 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097631587 | CMS |
| Novo Nordisk Inc | $17.76 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096597728 | CMS |
| Novo Nordisk Inc | $23.52 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096629362 | CMS |
| Novo Nordisk Inc | $14.32 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096846120 | CMS |
| PFIZER INC. | $26.97 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131492193 | CMS |
| PFIZER INC. | $25.68 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131653435 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.